Can I read SBRT vs Sorafenib in HCC Treatment on EtoBox?
SBRT vs Sorafenib in HCC Treatment by neke2000 is a document available to read on EtoBox.
What is SBRT vs Sorafenib in HCC Treatment about?
The NRG Oncology/RTOG 1112 Phase 3 trial compared the efficacy of stereotactic body radiation therapy (SBRT) followed by sorafenib to sorafenib alone in patients with locally advanced hepatocellular carcinoma (HCC). Results indicated that while SBRT was associated with improved overall survival (12.3 months for sorafenib vs 15.8 months for SBRT and sorafenib), the difference was not statistically significant. The study suggests that SBRT may benefit selected patients with HCC, particularly those with macrov
- Author
- neke2000
- Language
- EN